Clinical Trials Browser

Phase 2 × Interventional × evolocumab × Clear all

NCT06284564 2026-03-04

A Phase II Study Bolstering Outcomes by Optimizing Immunotherapy Strategies With Evolocumab and Nivolumab in Patients With Metastatic Renal Cell Carcinoma (BOOST-RCC)

Phase 2 Active not recruiting

Carcinoma, Renal Cell

NCT05144529 2025-04-17

TOP2101

Phase 2 Active not recruiting

Lung Cancer Metastatic